Pulse Biosciences Q3 EPS $(0.29) Beats $(0.31) Estimate, Sales $86.000K Miss $500.000K Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsEarnings MissesNews
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 38.1 percent decrease over losses of $(0.21) per share from
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 38.1 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $86.000 thousand which missed the analyst consensus estimate of $500.000 thousand by 82.80 percent.